Atlas Trials

Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

Clinical trial NCT06885957 · RECRUITING

Trial details

NCT number
NCT06885957
Sponsor
Tongji Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
NMO Spectrum Disorder
Start date
2025-07-01
Primary completion
2027-06-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.